The store will not work correctly when cookies are disabled.
(DL)-3-fluoro-4-methyl phenylglycine
ID: ALA4103658
Cas Number: 1239646-79-7
PubChem CID: 55271587
Max Phase: Preclinical
Molecular Formula: C9H10ClNO2
Molecular Weight: 199.64
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(C(N)C(=O)O)cc1Cl
Standard InChI: InChI=1S/C9H10ClNO2/c1-5-2-3-6(4-7(5)10)8(11)9(12)13/h2-4,8H,11H2,1H3,(H,12,13)
Standard InChI Key: FOLAWNHKMAFBKP-UHFFFAOYSA-N
Molfile:
RDKit 2D
13 13 0 0 0 0 0 0 0 0999 V2000
12.1118 -7.7481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8209 -7.3395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1118 -8.5695 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.3986 -7.3395 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.5341 -7.7481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2432 -7.3395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9565 -7.7481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9565 -8.5695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2432 -8.9822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5341 -8.5695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8209 -6.5182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6635 -7.3384 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.6644 -8.9777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
1 4 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
5 10 2 0
2 5 1 0
2 11 1 0
7 12 1 0
8 13 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 199.64 | Molecular Weight (Monoisotopic): 199.0400 | AlogP: 1.73 | #Rotatable Bonds: 2 |
Polar Surface Area: 63.32 | Molecular Species: ZWITTERION | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 1.77 | CX Basic pKa: 8.57 | CX LogP: -0.36 | CX LogD: -0.38 |
Aromatic Rings: 1 | Heavy Atoms: 13 | QED Weighted: 0.76 | Np Likeness Score: -0.67 |
References
1. (2014) D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders, |